患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 地域
• 登録日
•  

• Authorised

• Effect of three doses of nasal glp-1 versus placebo on postprandial hyperglycaemia in type 2 diabetes.
• postprandial hyperglycaemia in type 2 diabetes Classification code 10045242
• Denmark
• 2005-09-05

• Authorised

• Does stimulation of the receptor for Glucagon-like Peptide 1 (GLP-1) reduce alcohol intake in patients with alcohol dependence?
• Alcohol dependence MedDRA version: 20.0 Level: LLT Classification code 10001125 Term: Addiction System Organ Class: 100000004873 ;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
• Denmark
• 2017-01-27

• Authorised

• Anakinra to treat a gout attack
• Gout;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
• Netherlands
• 2014-07-03

• Authorised

• Efficacy and safety of anakinra (antagonist of the interleukin-1 receptor) in the treatment of periarticular inflammation in patients refractory to NSAID and / or steroids
• Inflammation in periarticular structures in patients refractory to NSAIDs and / or corticosteroids.;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
• Spain
• 2014-04-25

• Authorised

• A Phase 1/2a Study to Assess the Safety, Tolerability and Immunogenicity of Ad26.RSV.preF vaccine in Adults and Toddlers.
• Prophylactic respiratory syncytial virus (RSV) vaccine.;Therapeutic area: Diseases [C] - Virus Diseases [C02]
• Finland, United Kingdom
• 2017-08-04

• Authorised

• Efficacy and safety of the calcimimetic Cinacalcet in the management of patients with Primary Hyperparathyroidism due to a MEN-1 mutation - Cinacalcet in MEN-I PHPT
• Patients with primary hyperparathyroidism due to a germline mutation in the MEN-1 gene br>MedDRA version: 12.1 Level: LLT Classification code 10036693 Term: Primary hyperparathyroidism
• Netherlands
• 2010-02-08

• Authorised

• A Multi Center, Open label, Extension study of RA 1 using Extracoproreal photoimmune therapy with Uvadex
• Rheumatoid arthritis MedDRA version: 6.1 Level: PT Classification code 10039073
• Italy
• 2005-12-14

• Authorised

• A trial to assess the safety and efficacy of UX007 in patients with movement disorders associated with Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
• Glucose Transporter Type 1 deficiency syndrome MedDRA version: 19.1 Level: LLT Classification code 10061032 Term: Carbohydrate transport disorder System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
• Australia, France, Germany, Ireland, Israel, Italy, Netherlands, Spain, United Kingdom, United States
• 2017-03-10

• Authorised

• A Phase I study of MOv18 IgE
• Advanced unresectable solid tumour of a type known to express folate receptor alpha (FRa) in a percentage of cases for which no alternative therapy is felt to be appropriate. MedDRA version: 20.0 Level: PT Classification code 10014733 Term: Endometrial cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10016180 Term: Fallopian tube cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: HLGT Classification code 10027412 Term: Mesotheliomas System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10066697 Term: Ovarian cancer recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
• United Kingdom
• 2014-11-05

• Authorised

• Cilengitide (EMD121974) in combination with irradiation in children and young adults with newly diagnosed diffuse intrinsic pontine glioma : Phase I study - CILENT-0902
• Newly diagnosed diffuse intrinsic pontine glioma MedDRA version: 12.1 Level: LLT Classification code 10006143 Term: Brain stem glioma
• France
• 2010-03-16